SFG
MRNA icon

Steward Financial Group’s Moderna MRNA Stock Holding History

Steward Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$3K Buy
+30
New +$3.35K ﹤0.01% 856
2023
Q2 		– Sell
-59
Closed -$9K – 787
2023
Q1 		$9K Buy
59
+53
+883% +$8.74K ﹤0.01% 214
2022
Q4 		$1K Buy
+6
New +$981 ﹤0.01% 440
2022
Q3 		– Sell
-6
Closed – – 847
2022
Q2 		$0 Buy
+6
New +$858 ﹤0.01% 1218

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Steward Financial Group's MRNA Position: Q3 2023 in Review

Steward Financial Group opened a new position in Moderna (MRNA) in Q3 2023: 30 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #856 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in MRNA as recently as Q1 2023.

Steward Financial Group first reported a position in MRNA in Q2 2022 and has held it in 4 quarters since. The position peaked at $9K in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Steward Financial Group held 30 shares of Moderna worth $3K as of Q3 2023.
  • Moderna was a new Steward Financial Group position in Q3 2023.
  • Moderna made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #856 holding.
  • Steward Financial Group first reported a position in Moderna in Q2 2022 and has held it in 4 quarters since.
  • Steward Financial Group's Moderna position peaked at $9K in Q1 2023.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.